SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024191
Filing Date
2022-11-10
Accepted
2022-11-10 08:21:03
Documents
59
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-20220930.htm   iXBRL 10-Q 2903599
2 EX-10.1 rapt-ex10_1.htm EX-10.1 59238
3 EX-31.1 rapt-ex31_1.htm EX-31.1 22375
4 EX-31.2 rapt-ex31_2.htm EX-31.2 22386
5 EX-32.1 rapt-ex32_1.htm EX-32.1 24822
  Complete submission text file 0000950170-22-024191.txt   8549597

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rapt-20220930_lab.xml EX-101.LAB 331104
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rapt-20220930_def.xml EX-101.DEF 139844
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rapt-20220930.xsd EX-101.SCH 38436
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rapt-20220930_cal.xml EX-101.CAL 47268
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rapt-20220930_pre.xml EX-101.PRE 239366
53 EXTRACTED XBRL INSTANCE DOCUMENT rapt-20220930_htm.xml XML 1621373
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 221375086
SIC: 2834 Pharmaceutical Preparations